REAGENT AND PROCESS FOR PROTECTING NUCLEOSIDE ACTIVE GROUPS

Details for Australian Patent Application No. 2003234735 (hide)

Owner ISIS PHARMACEUTICALS, INC.

Inventors THEODORAKIS, Emmanuel, A.; WEN, Ke; SANGHVI, Yogesh, S.

Pub. Number AU-A-2003234735

PCT Number PCT/US03/11442

PCT Pub. Number WO2003/087053

Priority 10/120,649 11.04.02 US

Filing date 11 April 2003

Wipo publication date 27 October 2003

Event Publications

28 August 2003 Complete Application Filed

  Priority application(s): 10/120,649 11.04.02 US

4 December 2003 Application Open to Public Inspection

  Published as AU-A-2003234735

20 January 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

18 August 2005 Corrigenda

  Applications OPI - Name Index Under the name ISIS PHARMACEUTICALS, INC., Application No. 2003234735, under INID (71) correct the name to read THE REGENTS OF THE UNIVERSITY OF CALIFORNIA; ISIS PHARMACEUTICALS, INC. Corrigenda

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003234736-Methods of treatement using CTLA-4 antibodies

2003234734-PEPTIDE ANTAGONISTS OF TGFBETA FAMILY MEMBERS AND THERAPEUTIC USES THEREOF